EADO 2021 Comparison of triplet combinations with BRAF/MEK and PD-(L)1 inhibitors for advanced BRAFV600 ... Read more
EADO 2021 Circulating tumour DNA as a diagnostic, prognostic and predictive tool for melanoma patients? Read more
EADO 2021 Confirmed safety and efficacy of cemiplimab in patients with advanced cutaneous squamous cell ... Read more
EADO 2021 Adjuvant, neoadjuvant and up-front immunotherapy in loco-regionally advanced Merkel Cell Carci... Read more
EADO 2021 Recent developments of gene expression profiling as a prognostic biomarker in melanoma Read more
